|
The turbid combined fluidics management system (fms) was returned and visually inspected.No obvious defects were found.The small part tray, infusion cannula line, infusion and probe manifolds were not returned with the product.The spike was cut off.A lab stock spike was connected to the administration manifold for testing.The drain bag detached due to saturation.Both irrigation and aspiration luers were intact.Flare shape was observed in the blue socket fitting at the aspiration tubing insertion end.The product was tested using the console with the current software.The product could prime and tune with the sentry handpiece, the lab stock components successfully.No message code appeared on the screen.The ips/rps/aps (instant power supply/ redundant power system/ auxiliary power supply) sensor accuracy, aspiration and irrigation flow rate tests functioned per specification.The maximum vacuum level was -739.5 mmhg (millimeters of mercury) on the prime test results data.The product passed functionality per procedure.The investigation conducted a non-conformance review of the reported lot number.No relevant deviations were identified, all corresponding production release specifications defined in the device master record were met.Based on the evaluation of the information and materials received, the investigation was unable to identify the root cause or origin of the reported event as the product functioned per specifications.Additionally, no manufacturing-related deficiencies were found that potentially could have contributed to the complaint.No further investigative or manufacturing actions are warranted at this time due to the product meeting specifications.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaint data for all company products is reviewed monthly to monitor for adverse trends.During the last review, no adverse trends were observed for the reported product and event combination.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).
|